Hint mode is switched on Switch off
For swift navigation between sections

TAO Synergies

PDF download

Choose all Reset all
Download Cancel
Organization name
TAO Synergies Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

TAO Synergies Inc. operates as a biopharmaceutical company. The Company focuses on developing a product platform for the treatment of Alzheimer's disease, as well as evaluates therapeutic applications of bryostatin for neurodegenerative, cognitive, and dysfunctions such as fragile X syndrome, multiple sclerosis, and niemann-pick type C diseases.

Awards

News

13/10/2025 TAO Synergies: Entry Into A Material Definitive Agreement, Unregistered Sales Of Equity Securities, Regulation Fd, Other Events, Financial Statements And Exhibits
26/08/2025 TAO Synergies: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd, Other Events, Financial Statements And Exhibits
06/08/2025 TAO Synergies: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
17/07/2025 TAO Synergies: Regulation Fd, Other Events, Financial Statements And Exhibits
26/06/2025 Synaptogenix: To Correct This Statement Which Should Have Stated That Dr. Alan J. Tuchman, M.d. Remains A Member Of The Company’s Board Of Directors Despite His Resignation As Chief Executive Officer Of The Company, Amendments To Articles Of Incorporation, Regulation Fd, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    6199 FINANCE SERVICES
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001571934
  • EIN
    46-1585656
Registration is required to get access.